Annovis Bio Inc. Company Profile
NYSE: ANVSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.21+0.03 (+2.54%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Pre-market: 1.15 -4.17%
Annovis Bio at a glance
Annovis Bio Inc. (NYSE: ANVS) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector. The company's shares have traded publicly since 2020. At a market capitalization of $51.6 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001477845, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
Company information
- Legal name
- Annovis Bio Inc.
- Ticker
- NYSE: ANVS
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Headquarters
- United States
- IPO year
- 2020
- Market cap
- $51.64M
- SEC CIK
- 0001477845
Companies similar to Annovis Bio
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| SERSerina Therapeutics Inc. | 2.01 | -1.47% | $51.05M | vs ANVS |
| EDSAEdesa Biotech Inc. | 3.90 | +4.70% | $52.63M | vs ANVS |
| TLPHTalphera Inc. | 1.05 | -5.41% | $54.50M | vs ANVS |
| HYPDHyperion DeFi Inc. | 3.59 | -6.02% | $54.58M | vs ANVS |
| ELTXElicio Therapeutics Inc. | 1.85 | -1.60% | $48.62M | vs ANVS |
| DWTXDogwood Therapeutics Inc. | 1.43 | -5.92% | $48.61M | vs ANVS |
| ZYBTZhengye Biotechnology Holding Limited Class A | 1.16 | +4.50% | $54.97M | vs ANVS |
| CRVOCervoMed Inc. | 3.18 | -4.79% | $48.08M | vs ANVS |